Myth-buster
International consensus on MELAS finds L-arginine and other supplements still unproven for stroke-like episodes
As one of the first indexed systematic reviews on this specific pairing, this expert consensus challenges the belief that L-arginine helps — but because it’s an opinion-based statement, not a trial, it doesn’t settle the question either.
An expert panel reviewed the evidence and concluded that L-arginine, taurine, citrulline, CoQ10, and vitamins have no proven effect on reducing stroke-like episodes in MELAS syndrome. They recommend prompt antiseizure medications and multidisciplinary management instead. Since no dose or trial data were specified, and the findings rest on consensus rather than new experimental results, the caveat is that the evidence base remains too weak to recommend or dismiss these supplements definitively.
Where this fits in the evidence
This is among the first studies we've indexed on L-Arginine for Reduced Stroke-Like Episode Severity — treat it as an early signal until more research accumulates.
The study
Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.
- Systematic Review
- 2026-04
- European journal of neurology
- PubMed: 41999163
- DOI: 10.1111/ene.70588
- Full study breakdown →
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.